202 related articles for article (PubMed ID: 17537215)
1. Venous thromboembolism and cyproterone acetate in men with prostate cancer: a study using the General Practice Research Database.
Seaman HE; Langley SE; Farmer RD; de Vries CS
BJU Int; 2007 Jun; 99(6):1398-403. PubMed ID: 17537215
[TBL] [Abstract][Full Text] [Related]
2. Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: results from a randomised phase 3 study of the South European Uroncological Group.
Calais da Silva FE; Bono AV; Whelan P; Brausi M; Marques Queimadelos A; Martin JA; Kirkali Z; Calais da Silva FM; Robertson C
Eur Urol; 2009 Jun; 55(6):1269-77. PubMed ID: 19249153
[TBL] [Abstract][Full Text] [Related]
3. The risk of liver disorders in women prescribed cyproterone acetate in combination with ethinyloestradiol (Dianette): a nested case-control study using the GPRD.
Seaman HE; de Vries CS; Farmer RD
Pharmacoepidemiol Drug Saf; 2003; 12(7):541-50. PubMed ID: 14558177
[TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival.
Alcalay A; Wun T; Khatri V; Chew HK; Harvey D; Zhou H; White RH
J Clin Oncol; 2006 Mar; 24(7):1112-8. PubMed ID: 16505431
[TBL] [Abstract][Full Text] [Related]
5. The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case-control study using the General Practice Research Database.
Sundström A; Seaman H; Kieler H; Alfredsson L
BJOG; 2009 Jan; 116(1):91-7. PubMed ID: 19016686
[TBL] [Abstract][Full Text] [Related]
6. Incidence of venous thromboembolism and the impact on survival in breast cancer patients.
Chew HK; Wun T; Harvey DJ; Zhou H; White RH
J Clin Oncol; 2007 Jan; 25(1):70-6. PubMed ID: 17194906
[TBL] [Abstract][Full Text] [Related]
7. Fracture risk in Danish men with prostate cancer: a nationwide register study.
Abrahamsen B; Nielsen MF; Eskildsen P; Andersen JT; Walter S; Brixen K
BJU Int; 2007 Oct; 100(4):749-54. PubMed ID: 17822455
[TBL] [Abstract][Full Text] [Related]
8. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
Jick SS; Kaye JA; Russmann S; Jick H
Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
[TBL] [Abstract][Full Text] [Related]
9. A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy.
Douketis JD; Ginsberg JS; Holbrook A; Crowther M; Duku EK; Burrows RF
Arch Intern Med; 1997 Jul; 157(14):1522-30. PubMed ID: 9236553
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic and antidepressant drug use in the elderly and the risk of venous thromboembolism.
Ray JG; Mamdani MM; Yeo EL
Thromb Haemost; 2002 Aug; 88(2):205-9. PubMed ID: 12195690
[TBL] [Abstract][Full Text] [Related]
11. Inherited and acquired risk factors for venous thromboembolic disease among women taking tamoxifen to prevent breast cancer.
Duggan C; Marriott K; Edwards R; Cuzick J
J Clin Oncol; 2003 Oct; 21(19):3588-93. PubMed ID: 14512389
[TBL] [Abstract][Full Text] [Related]
12. The risk of venous thromboembolism in women prescribed cyproterone acetate in combination with ethinyl estradiol: a nested cohort analysis and case-control study.
Seaman HE; de Vries CS; Farmer RD
Hum Reprod; 2003 Mar; 18(3):522-6. PubMed ID: 12615818
[TBL] [Abstract][Full Text] [Related]
13. Association between venous thromboembolism and perioperative allogeneic transfusion.
Nilsson KR; Berenholtz SM; Garrett-Mayer E; Dorman T; Klag MJ; Pronovost PJ
Arch Surg; 2007 Feb; 142(2):126-32; discussion 133. PubMed ID: 17309963
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette): observational studies using the UK General Practice Research Database.
Seaman HE; de Vries CS; Farmer RD
Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):427-36. PubMed ID: 15269926
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents.
Liperoti R; Pedone C; Lapane KL; Mor V; Bernabei R; Gambassi G
Arch Intern Med; 2005 Dec 12-26; 165(22):2677-82. PubMed ID: 16344428
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study.
Khorana AA; Francis CW; Culakova E; Lyman GH
Cancer; 2005 Dec; 104(12):2822-9. PubMed ID: 16284987
[TBL] [Abstract][Full Text] [Related]
17. Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry.
Linnemann B; Zgouras D; Schindewolf M; Schwonberg J; Jarosch-Preusche M; Lindhoff-Last E
Blood Coagul Fibrinolysis; 2008 Mar; 19(2):159-65. PubMed ID: 18277138
[TBL] [Abstract][Full Text] [Related]
18. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
Fotopoulou C; duBois A; Karavas AN; Trappe R; Aminossadati B; Schmalfeldt B; Pfisterer J; Sehouli J;
J Clin Oncol; 2008 Jun; 26(16):2683-9. PubMed ID: 18509180
[TBL] [Abstract][Full Text] [Related]
19. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.
Canonico M; Oger E; Plu-Bureau G; Conard J; Meyer G; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
Circulation; 2007 Feb; 115(7):840-5. PubMed ID: 17309934
[TBL] [Abstract][Full Text] [Related]
20. [Therapy of prostatic cancer with cyproterone acetate].
Maier U
Wien Klin Wochenschr; 1988 Jan; 100(1):16-9. PubMed ID: 2964127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]